Fetal DNA does not induce preeclampsia-like symptoms when delivered in late pregnancy in the mouse

Abstract Introduction The etiology of preeclampsia is unclear. Fetal DNA is present in higher concentrations in the plasma of pregnant women suffering from preeclampsia than in the plasma of healthy pregnant women. A previously published study has shown that human fetal DNA injected into pregnant mi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Placenta (Eastbourne) 2017-04, Vol.52, p.100-105
Hauptverfasser: Čonka, Jozef, Konečná, Barbora, Lauková, Lucia, Vlková, Barbora, Celec, Peter
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 105
container_issue
container_start_page 100
container_title Placenta (Eastbourne)
container_volume 52
creator Čonka, Jozef
Konečná, Barbora
Lauková, Lucia
Vlková, Barbora
Celec, Peter
description Abstract Introduction The etiology of preeclampsia is unclear. Fetal DNA is present in higher concentrations in the plasma of pregnant women suffering from preeclampsia than in the plasma of healthy pregnant women. A previously published study has shown that human fetal DNA injected into pregnant mice induces preeclampsia-like symptoms when administered between gestation days 10–14. The aim of our experiment was to determine whether or not similar effects would be induced by administration of human and mouse fetal DNA, as well as mouse adult DNA and lipopolysaccharide during late pregnancy in the mouse. Methods Experimental animals were injected daily intraperitoneally during gestation days 14–18 with either saline – negative control, lipopolysaccharide – positive control, or various types of DNA. On gestation day 19, blood pressure and proteinuria were measured, and placental and fetal weights were recorded. Results Fetal and placental hypotrophy were induced only by lipopolysaccharide (p 
doi_str_mv 10.1016/j.placenta.2017.02.008
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1893551312</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0143400417301510</els_id><sourcerecordid>1893551312</sourcerecordid><originalsourceid>FETCH-LOGICAL-c423t-ade10569effbec23b8ff992df0700f6ce105c206079e634e8869d3260112cded3</originalsourceid><addsrcrecordid>eNqFkcFu1DAQhi0EotvCK1Q-ckk6YyfZ5IKoWgpIFRyAs-W1J9Rbxwl2UrRvj8O2HLhwsmT_38z4G8bOEUoEbC725eS1oTDrUgBuSxAlQPuMbbCWopAI4jnbAFayqACqE3aa0h4AugrFS3Yi2qqumg43bHdDs_b8-vMltyMlHsaZu2AXQ3yKRMbrYUpOF97dE0-HYZrHIfFfdxS4Je8eKJLNAPd6_kP8CDqYw3oz3xEfxiXRK_ai1z7R68fzjH2_ef_t6mNx--XDp6vL28JUQs6FtoRQNx31_Y6MkLu277tO2B62AH1j1lcjoIFtR42sqG2bzkrRAKIwlqw8Y2-Odac4_lwozWpwyZD3OlCeQ2HbybpGiSJHm2PUxDGlSL2aoht0PCgEtfpVe_XkV61-FQiV_Wbw_LHHshvI_sWehObAu2OA8k8fHEWVjKNgyLpIZlZ2dP_v8fafEsa74Iz293SgtB-XGLJHhSplQH1dt7wuGbcSsEaQvwEjKKSK</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1893551312</pqid></control><display><type>article</type><title>Fetal DNA does not induce preeclampsia-like symptoms when delivered in late pregnancy in the mouse</title><source>MEDLINE</source><source>ScienceDirect Freedom Collection (Elsevier)</source><creator>Čonka, Jozef ; Konečná, Barbora ; Lauková, Lucia ; Vlková, Barbora ; Celec, Peter</creator><creatorcontrib>Čonka, Jozef ; Konečná, Barbora ; Lauková, Lucia ; Vlková, Barbora ; Celec, Peter</creatorcontrib><description>Abstract Introduction The etiology of preeclampsia is unclear. Fetal DNA is present in higher concentrations in the plasma of pregnant women suffering from preeclampsia than in the plasma of healthy pregnant women. A previously published study has shown that human fetal DNA injected into pregnant mice induces preeclampsia-like symptoms when administered between gestation days 10–14. The aim of our experiment was to determine whether or not similar effects would be induced by administration of human and mouse fetal DNA, as well as mouse adult DNA and lipopolysaccharide during late pregnancy in the mouse. Methods Experimental animals were injected daily intraperitoneally during gestation days 14–18 with either saline – negative control, lipopolysaccharide – positive control, or various types of DNA. On gestation day 19, blood pressure and proteinuria were measured, and placental and fetal weights were recorded. Results Fetal and placental hypotrophy were induced only by lipopolysaccharide (p &lt; 0.001). Neither fetal nor adult DNA induced changes in fetal/placental weight. None of the experimental groups had higher blood pressure or urinary protein in comparison to saline treated animals. Discussion In our experiment, we found that there was no effect from intraperitoneally injected human fetal DNA, mouse fetal DNA, or mouse adult DNA on pregnant mice. Additionally, relatively high doses of various types of DNA did not induce preeclampsia-like symptoms in mice when administered in late pregnancy. Our negative results support the hypothesis that the increase of fetal DNA circulating in maternal circulation during the third trimester is rather a consequence than a cause of preeclampsia.</description><identifier>ISSN: 0143-4004</identifier><identifier>EISSN: 1532-3102</identifier><identifier>DOI: 10.1016/j.placenta.2017.02.008</identifier><identifier>PMID: 28454691</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Animals ; Blood Pressure - physiology ; Cell-free DNA ; Cell-Free Nucleic Acids - administration &amp; dosage ; Disease Models, Animal ; Female ; Fetal hypotrophy ; Fetal nucleic acid ; Internal Medicine ; Lipopolysaccharides ; Mice ; Obstetrics and Gynecology ; Placenta - physiopathology ; Pre-Eclampsia - etiology ; Pre-Eclampsia - physiopathology ; Preeclampsia ; Pregnancy ; Pregnancy complication</subject><ispartof>Placenta (Eastbourne), 2017-04, Vol.52, p.100-105</ispartof><rights>2017 Elsevier Ltd</rights><rights>Copyright © 2017 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c423t-ade10569effbec23b8ff992df0700f6ce105c206079e634e8869d3260112cded3</citedby><cites>FETCH-LOGICAL-c423t-ade10569effbec23b8ff992df0700f6ce105c206079e634e8869d3260112cded3</cites><orcidid>0000-0001-5883-3580</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.placenta.2017.02.008$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28454691$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Čonka, Jozef</creatorcontrib><creatorcontrib>Konečná, Barbora</creatorcontrib><creatorcontrib>Lauková, Lucia</creatorcontrib><creatorcontrib>Vlková, Barbora</creatorcontrib><creatorcontrib>Celec, Peter</creatorcontrib><title>Fetal DNA does not induce preeclampsia-like symptoms when delivered in late pregnancy in the mouse</title><title>Placenta (Eastbourne)</title><addtitle>Placenta</addtitle><description>Abstract Introduction The etiology of preeclampsia is unclear. Fetal DNA is present in higher concentrations in the plasma of pregnant women suffering from preeclampsia than in the plasma of healthy pregnant women. A previously published study has shown that human fetal DNA injected into pregnant mice induces preeclampsia-like symptoms when administered between gestation days 10–14. The aim of our experiment was to determine whether or not similar effects would be induced by administration of human and mouse fetal DNA, as well as mouse adult DNA and lipopolysaccharide during late pregnancy in the mouse. Methods Experimental animals were injected daily intraperitoneally during gestation days 14–18 with either saline – negative control, lipopolysaccharide – positive control, or various types of DNA. On gestation day 19, blood pressure and proteinuria were measured, and placental and fetal weights were recorded. Results Fetal and placental hypotrophy were induced only by lipopolysaccharide (p &lt; 0.001). Neither fetal nor adult DNA induced changes in fetal/placental weight. None of the experimental groups had higher blood pressure or urinary protein in comparison to saline treated animals. Discussion In our experiment, we found that there was no effect from intraperitoneally injected human fetal DNA, mouse fetal DNA, or mouse adult DNA on pregnant mice. Additionally, relatively high doses of various types of DNA did not induce preeclampsia-like symptoms in mice when administered in late pregnancy. Our negative results support the hypothesis that the increase of fetal DNA circulating in maternal circulation during the third trimester is rather a consequence than a cause of preeclampsia.</description><subject>Animals</subject><subject>Blood Pressure - physiology</subject><subject>Cell-free DNA</subject><subject>Cell-Free Nucleic Acids - administration &amp; dosage</subject><subject>Disease Models, Animal</subject><subject>Female</subject><subject>Fetal hypotrophy</subject><subject>Fetal nucleic acid</subject><subject>Internal Medicine</subject><subject>Lipopolysaccharides</subject><subject>Mice</subject><subject>Obstetrics and Gynecology</subject><subject>Placenta - physiopathology</subject><subject>Pre-Eclampsia - etiology</subject><subject>Pre-Eclampsia - physiopathology</subject><subject>Preeclampsia</subject><subject>Pregnancy</subject><subject>Pregnancy complication</subject><issn>0143-4004</issn><issn>1532-3102</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFu1DAQhi0EotvCK1Q-ckk6YyfZ5IKoWgpIFRyAs-W1J9Rbxwl2UrRvj8O2HLhwsmT_38z4G8bOEUoEbC725eS1oTDrUgBuSxAlQPuMbbCWopAI4jnbAFayqACqE3aa0h4AugrFS3Yi2qqumg43bHdDs_b8-vMltyMlHsaZu2AXQ3yKRMbrYUpOF97dE0-HYZrHIfFfdxS4Je8eKJLNAPd6_kP8CDqYw3oz3xEfxiXRK_ai1z7R68fzjH2_ef_t6mNx--XDp6vL28JUQs6FtoRQNx31_Y6MkLu277tO2B62AH1j1lcjoIFtR42sqG2bzkrRAKIwlqw8Y2-Odac4_lwozWpwyZD3OlCeQ2HbybpGiSJHm2PUxDGlSL2aoht0PCgEtfpVe_XkV61-FQiV_Wbw_LHHshvI_sWehObAu2OA8k8fHEWVjKNgyLpIZlZ2dP_v8fafEsa74Iz293SgtB-XGLJHhSplQH1dt7wuGbcSsEaQvwEjKKSK</recordid><startdate>20170401</startdate><enddate>20170401</enddate><creator>Čonka, Jozef</creator><creator>Konečná, Barbora</creator><creator>Lauková, Lucia</creator><creator>Vlková, Barbora</creator><creator>Celec, Peter</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5883-3580</orcidid></search><sort><creationdate>20170401</creationdate><title>Fetal DNA does not induce preeclampsia-like symptoms when delivered in late pregnancy in the mouse</title><author>Čonka, Jozef ; Konečná, Barbora ; Lauková, Lucia ; Vlková, Barbora ; Celec, Peter</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c423t-ade10569effbec23b8ff992df0700f6ce105c206079e634e8869d3260112cded3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Animals</topic><topic>Blood Pressure - physiology</topic><topic>Cell-free DNA</topic><topic>Cell-Free Nucleic Acids - administration &amp; dosage</topic><topic>Disease Models, Animal</topic><topic>Female</topic><topic>Fetal hypotrophy</topic><topic>Fetal nucleic acid</topic><topic>Internal Medicine</topic><topic>Lipopolysaccharides</topic><topic>Mice</topic><topic>Obstetrics and Gynecology</topic><topic>Placenta - physiopathology</topic><topic>Pre-Eclampsia - etiology</topic><topic>Pre-Eclampsia - physiopathology</topic><topic>Preeclampsia</topic><topic>Pregnancy</topic><topic>Pregnancy complication</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Čonka, Jozef</creatorcontrib><creatorcontrib>Konečná, Barbora</creatorcontrib><creatorcontrib>Lauková, Lucia</creatorcontrib><creatorcontrib>Vlková, Barbora</creatorcontrib><creatorcontrib>Celec, Peter</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Placenta (Eastbourne)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Čonka, Jozef</au><au>Konečná, Barbora</au><au>Lauková, Lucia</au><au>Vlková, Barbora</au><au>Celec, Peter</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fetal DNA does not induce preeclampsia-like symptoms when delivered in late pregnancy in the mouse</atitle><jtitle>Placenta (Eastbourne)</jtitle><addtitle>Placenta</addtitle><date>2017-04-01</date><risdate>2017</risdate><volume>52</volume><spage>100</spage><epage>105</epage><pages>100-105</pages><issn>0143-4004</issn><eissn>1532-3102</eissn><abstract>Abstract Introduction The etiology of preeclampsia is unclear. Fetal DNA is present in higher concentrations in the plasma of pregnant women suffering from preeclampsia than in the plasma of healthy pregnant women. A previously published study has shown that human fetal DNA injected into pregnant mice induces preeclampsia-like symptoms when administered between gestation days 10–14. The aim of our experiment was to determine whether or not similar effects would be induced by administration of human and mouse fetal DNA, as well as mouse adult DNA and lipopolysaccharide during late pregnancy in the mouse. Methods Experimental animals were injected daily intraperitoneally during gestation days 14–18 with either saline – negative control, lipopolysaccharide – positive control, or various types of DNA. On gestation day 19, blood pressure and proteinuria were measured, and placental and fetal weights were recorded. Results Fetal and placental hypotrophy were induced only by lipopolysaccharide (p &lt; 0.001). Neither fetal nor adult DNA induced changes in fetal/placental weight. None of the experimental groups had higher blood pressure or urinary protein in comparison to saline treated animals. Discussion In our experiment, we found that there was no effect from intraperitoneally injected human fetal DNA, mouse fetal DNA, or mouse adult DNA on pregnant mice. Additionally, relatively high doses of various types of DNA did not induce preeclampsia-like symptoms in mice when administered in late pregnancy. Our negative results support the hypothesis that the increase of fetal DNA circulating in maternal circulation during the third trimester is rather a consequence than a cause of preeclampsia.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>28454691</pmid><doi>10.1016/j.placenta.2017.02.008</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-5883-3580</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0143-4004
ispartof Placenta (Eastbourne), 2017-04, Vol.52, p.100-105
issn 0143-4004
1532-3102
language eng
recordid cdi_proquest_miscellaneous_1893551312
source MEDLINE; ScienceDirect Freedom Collection (Elsevier)
subjects Animals
Blood Pressure - physiology
Cell-free DNA
Cell-Free Nucleic Acids - administration & dosage
Disease Models, Animal
Female
Fetal hypotrophy
Fetal nucleic acid
Internal Medicine
Lipopolysaccharides
Mice
Obstetrics and Gynecology
Placenta - physiopathology
Pre-Eclampsia - etiology
Pre-Eclampsia - physiopathology
Preeclampsia
Pregnancy
Pregnancy complication
title Fetal DNA does not induce preeclampsia-like symptoms when delivered in late pregnancy in the mouse
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T16%3A02%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fetal%20DNA%20does%20not%20induce%20preeclampsia-like%20symptoms%20when%20delivered%20in%20late%20pregnancy%20in%20the%20mouse&rft.jtitle=Placenta%20(Eastbourne)&rft.au=%C4%8Conka,%20Jozef&rft.date=2017-04-01&rft.volume=52&rft.spage=100&rft.epage=105&rft.pages=100-105&rft.issn=0143-4004&rft.eissn=1532-3102&rft_id=info:doi/10.1016/j.placenta.2017.02.008&rft_dat=%3Cproquest_cross%3E1893551312%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1893551312&rft_id=info:pmid/28454691&rft_els_id=1_s2_0_S0143400417301510&rfr_iscdi=true